Ó£ÌÒÊÓƵ

More children treated with GLP-1 weight loss drugs

Ó£ÌÒÊÓƵ senior medical analyst Dr. Marc Siegel discusses the debate over children being treated with these drugs and more on 'America Reports.'

Ó£ÌÒÊÓƵ medical analyst Dr. Marc Siegel discusses the controversial trend of parents turning to GLP-1 weight-loss drugs, like Wegovy, for their obese children. He explores the potential long-term side effects on young digestive systems and eyes. Siegel also highlights the alarming increase in childhood obesity rates, from approximately 5% in 1970 to 21% by 2023, attributing it to processed foods and sedentary lifestyles.